Lev Gerlovin is a speaker during the session titled “Assess Value When Innovating to Establish Greater Benefits Relative to Costs.”
For more information on this event, click here.
Supporting appropriate recognition and action for vaccination in AMR National Action Plans
Antimicrobial Resistance (AMR) is a serious and increasing threat to global health security and impacts the efficacy of medicines we have come to rely on, made...